A Review of the State of Purinergic Signaling and Psychological Stress

REN Wen-Jing, TANG Yong

Abstract

Purinergic signaling is involved in multiple physiological and pathological processes. Psychological stress, as an inharmonious state in response to stressors, is closely related to the function or dysfunction of purinergic signaling. Abnormal expression of ATP interceptors caused by stress leads to psychological stress-related diseases, such as anxiety, depression, post-traumatic stress disorder and schizophrenia. Recent studies demonstrate that a complex network of purinergic signaling (such as ATP, adenosine and P2X2R, P2X3R, P2X4R, P2X7R, A1R, A2AR) plays a key role in psychological stress, but the specific mechanism remains to be further studied. And few studies focus on the application of ATP real-time detecting to psychological stress animal models, so the specific biological role of ATP in the process of stress is still unknown. This review will summarize the relationship between purinergic signaling and psychological stress and propose to apply the duplicate ATP real-time detection technology and purinergic compounds on psychological stress research in order to provide novel potential targets for the treatment of stress-related diseases.

 

Kewords: Purinergic signaling, Psychological stress, ATP, Adenosine, Purinergic receptor

 

Full Text:

PDF


References


BURNSTOCK G. Purinergic nerves. Pharmacol Rev，1972，24(3): 509–581.

BURNSTOCK G. Introduction to purinergic signaling. Methods Mol Biol，2020，2041: 1–15.

BURNSTOCK G. Purinergic receptors. J Theor Biol，1976，62(2): 491–503.

LONDOS C， COOPER D M， WOLFF J. Subclasses of external adenosine receptors. Proc Natl Acad Sci U S A，1980，77(5): 2551–2554.

VAN CALKER D， MÜLLER M， HAMPRECHT B. Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J Neurochem，1979，33(5): 999–1005.

BURNSTOCK G， KENNEDY C. Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol，1985，16(5): 433–440.

FREDHOLM B B， AP I J， JACOBSON K A， et al. International union of pharmacology. ⅩⅩⅤ. Nomenclature and classification of adenosine receptors. Pharmacol Rev，2001，53(4): 527–552.

LUSTIG K D， SHIAU A K， BRAKE A J， et al. Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc Natl Acad Sci U S A，1993，90(11): 5113–5117.

BRAKE A J， WAGENBACH M J， JULIUS D. New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature，1994，371(6497): 519–523.

ZHAO W， ZHANG Y， JI R， et al. Expression of P2X receptors in the rat anterior pituitary. Purinerg Signal，2020，16(1): 17–28.

BURNSTOCK G. Purine and purinergic receptors. Brain Neurosci Adv， 2018， 2: 2398212818817494[2020-12-28]. https://www.ncbi.nlm.nih. gov/pmc/articles/PMC7058212/. doi: 10.1177/2398212818817494.

TANG Z， YE W， CHEN H， et al. Role of purines in regulation of metabolic reprogramming. Purinerg Signal，2019，15(4): 423–438.

BELLEFEUILLE S D， MOLLE C M， GENDRON F P. Reviewing the role of P2Y receptors in specific gastrointestinal cancers. Purinerg Signal， 2019，15(4): 451–463.

VELÁZQUEZ-MIRANDA E， DÍAZ-MUÑOZ M， VÁZQUEZ-CUEVAS F G. Purinergic signaling in hepatic disease. Purinerg Signal，2019，15(4): 477–489.

KRÜGEL U. Purinergic receptors in psychiatric disorders. Neuropharmacology，2016，104: 212–225.

JACOBSON K A， MÜLLER C E. Medicinal chemistry of adenosine, P2Y and P2X receptors. Neuropharmacology，2016，104: 31–49.

ORTIZ R， ULRICH H， ZARATE C A， Jr， et al. Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics. Prog Neuropsychopharmacol Biol Psychiatry，2015，57: 117–131.


Refbacks

  • There are currently no refbacks.